Rhythm Pharmaceuticals, Inc. (RYTM)
NGM · Common · CUSIP 76243J105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RYTM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
76243J105
Market Cap
Mid Cap · $630 Million
IPO
10/4/2017 · $17.00/share
Business: Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.

Company Contact

CEO
David Meeker
CFO
Hunter Smith
Headquarters
500 Boylston Street, 11th Floor, Boston, MA 02116
Phone
857-264-4280
Fax
857-264-4299
Investor Relations
Hannah Deresiewicz, Stern IR · 212-362-1200 · hannahd@sternir.com
General Email
info@rhythmtx.com
SEC EDGAR Filings
View filings »